Regencell Bioscience Holdings Ltd (RGC): Total Assets

Annual figures by period end, from SEC filings.

$5.76M
As of 2025-06-30
-31.6%
3-year compound annual growth
+62.1%
5-year compound annual growth
$18.02M2020-06-30: $514.0K2021-06-30: $340.1K2022-06-30: $18.02M2023-06-30: $12.62M2024-06-30: $8.44M2025-06-30: $5.76M$5.76M
2020-06-30 Total Assets (USD) 2025-06-30
Period endedTotal AssetsChange YoYSource filing
2025-06-30$5.76M-31.8%2025-10-31, Balance as of period end
2024-06-30$8.44M-33.1%2025-10-31, Balance as of period end
2023-06-30$12.62M-30.0%2024-10-25, Balance as of period end
2022-06-30$18.02Mn/m2023-10-27, Balance as of period end
2021-06-30$340.1K-33.8%2022-10-31, Balance as of period end
2020-06-30$514.0Kn/a2021-10-29, Balance as of period end

Total Assets at similar companies

Companies with the same SEC industry code (Medicinal Chemicals & Botanical Products), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedTotal AssetsChange YoY
Regencell Bioscience Holdings Ltd (RGC)2025-06-30$5.76M-31.8%
Target Group Inc. (CBDY)2025-12-31$6.18M-18.4%
TFA Therapeutics, Inc. (RAJAF)2025-12-31$4.66M+0.7%
Functional Brands Inc. (MEHA)2025-12-31$9.11M+27.0%
Synergy CHC Corp. (SNYRQ)2025-12-31$10.16M-37.8%
Charlie's Holdings, Inc. (CHUC)2025-12-31$11.56M+193.1%
Cyanotech Corp (CYAN)2025-03-31$23.49M-6.5%
Healthy Extracts Inc. (HYEX)2025-12-31$27.82Mn/m
Mannatech Inc (MTEX)2025-12-31$29.99M-16.8%

Compare RGC, CBDY, RAJAF, MEHA side by side · Screen every company in Medicinal Chemicals & Botanical Products ↗